Advanced Esophageal Carcinoma

7 clinical trials · Condition

Record	Firm	Date
A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer (NCT06745193)	Peking University	2025-02-01
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer (NCT05705492)	OHSU Knight Cancer Institute	2024-07-17
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer (NCT05969860)	Mayo Clinic	2023-08-23
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (NCT04491942)	National Cancer Institute (NCI)	2021-08-25
FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma (NCT02023593)	Yuhong Li	2012-03-01
mFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus (NCT01486992)	Peking University	2011-11-01
mFOLFIRI as the Second Line Chemotherapy for Advanced Esophageal Carcinoma After Failure of 1st Line Treatment of Paclitaxel/DDP : a Phase II Single Center Prospective Clinical Trial (NCT01044420)	Peking University	2009-05-01

Every clearance here is in the API, with alerts when new ones post.